UroGen Pharma Ltd.
UroGen Pharma Ltd. scores highest on Torque (96) and lowest on Price (0). Its PosiPenta is 55.32 out of 100, around the middle of similar companies.
On the Penta Grid this week, UroGen Pharma Ltd. is Grid #210 of 837 in the Healthcare sector in United States, and Grid #1,218 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| UroGen Pharma Ltd. | 55.32 | 0 | 62 | 72 | 96 | 46 |
| Kailera Therapeutics, Inc. | 45.27 | 36 | 21 | 35 | 75 | 59 |
| Healthcare Services Group, Inc. | 63.84 | 62 | 50 | 78 | 78 | 52 |
| ANI Pharmaceuticals, Inc. | 64.05 | 58 | 88 | 57 | 54 | 63 |
| Ardent Health, Inc. | 68.57 | 65 | 83 | 77 | 49 | 69 |
| Schrödinger, Inc. | 42.47 | 13 | 32 | 70 | 52 | 45 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -17.54 |
| P/B ratio | -12.76 |
EEarnings
| Trailing EPS | ₹-186.59 |
| Forward EPS | ₹245.04 |
NNitro
| Price | 3273.35 |
| 52-week high | 4812.47 |
| 52-week low | 1550.01 |
| Fall from 52-week high | 32.0% |
TTorque
| Return on equity (ROE) | — |
| Debt-to-equity | -1.22 |
AAnchor
| Beta (price swings) | 1.58 |
| Market cap | ₹16,000 Cr |
| Insider holding | 3.49% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is UroGen Pharma Ltd.'s PosiPenta score?
UroGen Pharma Ltd.'s PosiPenta is 55.32 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does UroGen Pharma Ltd. stand on the Penta Grid?
On the Penta Grid this week, UroGen Pharma Ltd. is Grid #210 of 837 in the Healthcare sector in United States, and Grid #1,218 of 4,000 in United States.
Which PosiPenta pillar is strongest for UroGen Pharma Ltd.?
Torque (durability), with a score of 96 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for UroGen Pharma Ltd.?
Price (valuation), with a score of 0 out of 100: much weaker than most similar companies.
Has UroGen Pharma Ltd.'s PosiPenta changed since last week?
Yes, it rose 1.78 points, from 53.54 to 55.32.
PositoAI is for research and education only and is not investment advice.